(Total Views: 607)
Posted On: 04/10/2020 7:49:01 AM
Post# of 148884
Here’s the part of the article that addresses Cytodyn
“CytoDyn Inc., a Vancouver, Wash.-based biotech company, said 10 severely sick Covid-19 patients showed signs of recovering three days after being infused with its experimental HIV drug leronlimab, which may block the production of inflammatory cytokines. Three of the patients were taken off ventilators, including two who have since been discharged from care, according to CytoDyn.
The company is studying its drug in a trial for patients with mild-to-moderate symptoms and expects to start one for severely sick patients”
“CytoDyn Inc., a Vancouver, Wash.-based biotech company, said 10 severely sick Covid-19 patients showed signs of recovering three days after being infused with its experimental HIV drug leronlimab, which may block the production of inflammatory cytokines. Three of the patients were taken off ventilators, including two who have since been discharged from care, according to CytoDyn.
The company is studying its drug in a trial for patients with mild-to-moderate symptoms and expects to start one for severely sick patients”
(2)
(1)Scroll down for more posts ▼
